Search Results For :: danaher
-
Creatinine Measurement Market by Product (Kits, Reagents), Test Type (Jaffe method, Enzymatic creatinine method), Sample (Serum Creatinine, Urine) and End User (Hospitals, Diagnostic Laboratories), Region (North America, Europe) - Global Forecasts to 2023
The global creatinine measurement market is projected to reach USD 564.5 Million by 2023, at a CAGR of 8.4%. The growth of this market is mainly driven by increasing incidence of renal disorders, growing incidence of other chronic disorders impacting renal function, rising awareness and adoption of preventive healthcare approaches, implementation of favorable government initiatives to promote renal health, rapid growth in the geriatric population, and increasing number of drug development initiatives. The creatinine measurement market is highly fragmented with the presence of several large as well as emerging players. Prominent players in this market include F. Hoffmann-la Roche Ltd (Switzerland)., Abbott Laboratories (US), Danaher Corporation (US), Thermo Fisher Scientific Inc (US), Siemens Healthineers (Germany), Randox Laboratories (UK)., Pointe Scientific, Inc (US), Sentinel Ch. Spa. (Italy), Diasys Diagnostic Systems GmbH (Germany), Dialab GmbH (Vienna), Diazyme Laboratories, Inc (US), Wako Pure Chemical Industries, Ltd. (Japan), Ortho Clinical Diagnostics (US), and Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China).
- Published: June 2018
- Price: $ 4950
- TOC Available:
-
Biomarker Technologies Market by Profiling Technology (Chromatography, NGS, PCR, Mass Spectrometry, Immunoassay, Liquid Biopsy (ddPCR, DHPLC)), Research Area (Proteomics, Lipidomics), Application (Biomarker Validation, Biomarker Discovery) & Geography
The global biomarker technologies market is projected to grow at a CAGR of 9.7%. The key players in the biomarker technologies market are Thermo Fisher Scientific (US), Agilent Technologies (US), Roche (Switzerland), Danaher Corporation (US), Waters Corporation (US), Shimadzu Corporation (Japan), and Bio-Rad Laboratories (US).
- Published: May 2018
- Price: $ 15000
- TOC Available:
-
EMEA 3D CBCT/Cone Beam CT Systems Market by Application (Dental (Oral and Maxillofacial Surgery, Implantology, Orthodontic, Endodontic) and Non-Dental (Radiology, ENT)), End User (Hospitals and Clinics, Diagnostic Centres) - Forecast to 2023
The EMEA 3D CBCT systems market is projected to reach USD 300.4 Million by 2023 from USD 194.3 Million in 2018, at a CAGR of 9.0%. The growing number of dentists is one of the major drivers for the growth of the dental CBCT market in this region. This increase, along with the subsequent establishment of new clinics and rising government spending on healthcare, has contributed to a growing demand for dental equipment like CBCT systems. The key players in the EMEA 3D CBCT systems market are Danaher Corporation (US), DENTSPLY SIRONA (US), Carestream Dental (US), Planmeca Group (Finland), VATECH (South Korea), CEFLA (Italy), J. MORITA CORPORATION (Japan), ACTEON GROUP (France), Asahi Roentgen (Japan), and Genoray (South Korea).
- Published: May 2018
- Price: $ 4950
- TOC Available:
-
Colposcopy Market by Instrument Type (Optical, Digital), Portability (Fixed, Portable, Handheld), Application (Cervical Cancer Diagnosis, Physical Examination), End User (Hospitals, Clinics, Diagnostic Centres), and Region - Global Forecasts to 2023
The global colposcopy market is projected to reach USD 740.1 Million by 2023, at a CAGR of 6.8%. Market growth can largely be attributed to factors such as the heavy burden of cervical cancer, the rapidly growing geriatric population, and technological advancements in colposcopy. Increasing awareness about gynecological diseases and the emerging Asian markets are expected to present a wide array of growth opportunities for players in the market. Key players in the Colposcopy market include DySIS (US), CooperSurgical (US), Atmos (Germany), Olympus (Japan), Karl Kaps (Germany), McKesson (US), Danaher (US), and Carl Zeiss (Germany).
- Published: March 2018
- Price: $ 4950
- TOC Available:
-
Thyroid Function Test Market by Type (TSH Tests, T4 Tests, T3 Tests), End User (Hospitals, Diagnostic Laboratories, Research Laboratories & Institutes), and Region (North America, Europe, APAC, LATAM, and MEA)
The global thyroid function test market is expected to grow at a CAGR of 5.9%. This growth can be attributed to factors such as increasing incidence of thyroid disorders, increasing awareness about thyroid disorders, increasing prevalence of lifestyle diseases, rising geriatric population, and increasing consumption of alcohol and tobacco. The prominent players in the global thyroid function tests market include Thermo Fisher (US), Abbott (US), Roche (Switzerland), DiaSorin (Italy), Danaher (US), Kronus (US), Merck (Germany), Cortez Diagnostics (US), bioMérieux (France), Qualigen (US), and Autobio Diagnostics (China).
- Published: February 2018
- Price: $ 4950
- TOC Available:
-
RSV Diagnostics Market by Product (Kits and Assays, Instruments), Method (Rapid Antigen Detection Test (Immunofluorescence Assay, ELISA), Molecular Diagnostic), End User (Hospitals & Clinics, Clinical Laboratories, Homecare) & Region
The global RSV diagnostics market is expected to grow at a CAGR of 10.1%. Market growth is primarily driven by the rising burden of RSV infections, growing demand for PoC molecular diagnostic tests for the diagnosis of RSV infections, and increasing approval of RSV diagnostic kits and assays. Key players in the RSV diagnostics market include bioMérieux (France), Becton Dickinson (US), Abbott (US), Roche (Switzerland), Danaher (US), Luminex (US), BioCartis (Belgium), Hologic (US), and Fast Track Diagnostics (Luxembourg).
- Published: February 2018
- Price: $ 4950
- TOC Available:
-
Reaction Monitoring Market by Technology (Spectroscopy (MS, IR, UV, NMR, Raman), Chromatography (GC, LC), Calorimetry, Titrimetry, XRD), Mode (Quantitative, Qualitative), End User (Research, Pharma-Biotech, Food & Beverages Co) - Global Forecasts to 2022
The global reaction monitoring market is projected to reach USD 1.52 Billion by 2022 from USD 1.15 Billion in 2017, at a CAGR of 5.7%. Factors such as stringent regulatory guidelines in the pharmaceutical & biotechnology industry; expansion of the food and beverages industry; and increasing public-private investments in life science research are driving the reaction monitoring market. The major players in the market are Agilent (US), Danaher (US), PerkinElmer (US), Shimadzu (Japan), Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), Bruker (US), Waters (US), Hitachi High-Technologies (Japan), Merck (Germany), ABB (Switzerland), Mettler-Toledo International (US) , and HORIBA (Japan).
- Published: October 2017
- Price: $ 4950
- TOC Available:
-
Endodontics Market by Instruments (Scalers, Apex Locator, Motors, Handpiece, Laser), Consumables (Access Cavity Preparation, Endodontic Files, Burs, Drill, Lubricant, Obturation), End User (Clinic, Hospital) - Global Forecast to 2022
The global endodontics market is projected to reach USD 1.61 Billion by 2022 from USD 1.26 Billion in 2017, at a CAGR of 5.1% during the forecast period. Growth in this market is attributed to the rapid growth in the geriatric population, increasing number of dentists and dental practices, rising dental tourism, increasing dental expenditure, and an increase in disposable incomes. The prominent players in the endodontics market are DENTSPLY SIRONA (US), Danaher Corporation (US), Ivoclar Vivadent (Liechtenstein), Ultradent Products (US), Septodont Holding (France), FKG Dentaire (Switzerland), Brasseler USA (US), MICRO-MEGA (France), DiaDent Group International (Canada), MANI (Japan), COLTENE Holding (Switzerland), and VOCO (Germany).
- Published: September 2017
- Price: $ 4950
- TOC Available:
-
Molecular Spectroscopy Market by Technology (NMR (FT, Continuous Wave), UV-Visible (Array-based, Dual-beam), IR (Terahertz, Benchtop), NIR (FT-NIR), Raman (SERS, TERS, FT Raman)), Application (Pharmaceutical, Food, Biotechnology) - Global Forecast to 2022
The global molecular spectroscopy market is expected to reach USD 6.85 Billion by 2022 from USD 4.98 Billion in 2017, at a CAGR of 6.6%. The growth of this market is majorly driven by food safety concerns, the growth of the pharmaceutical and biotechnology industry, technological advancements in molecular spectroscopy and application of molecular spectroscopy in environmental screening. Bruker Corporation (US), Thermo Fisher Scientific, Inc. (US), PerkinElmer, Inc. (US), and Agilent Technologies, Inc. (US) are the key players in the molecular spectroscopy market. Other players include Shimadzu Corporation (Japan), Danaher Corporation (US), ABB (Switzerland), Merck KGaA (Germany), JEOL Ltd (Japan), FOSS (Denmark), JASCO, Inc. (US), and HORIBA Ltd. (US).
- Published: August 2017
- Price: $ 4950
- TOC Available:
-
IVD Market in BRIC by Product & Service (Instruments, Reagents, Software), Technology (Immunoassay, Hematology, Microbiology), Application (Diabetes, Cardiology, Infectious Diseases), Country (Brazil, Russia, India, China) - Forecast to 2022
The BRIC IVD Market and other emerging countries is expected to reach USD 15.71 Billion by 2022 from USD 10.60 Billion in 2017, at a CAGR of 8.2%. The key factors driving the growth of the market are growing patient awareness of personalized medicine, increasing prevalence of lifestyle and chronic diseases, growth in the number of private diagnostic centers, and improving healthcare system in emerging countries. However, market growth is restrained by the lack of reimbursement and the slow growth of the economy in some emerging countries.
- Published: May 2017
- Price: $ 4950
- TOC Available:
Records 71 to 80 of 93